-5%
Azmasol Plus Inhaler | Salbutamol + Budesonide 90 mcg+80 mcg)/puff is indicated for:
- Management of asthma in patients aged 18 years and above
- Prevention of bronchoconstriction
- Reduction in the frequency of asthma exacerbations
Azmasol Plus is a combination of:
- Salbutamol: A short-acting β₂-adrenergic agonist that relaxes airway smooth muscles from the trachea to the bronchioles, resulting in rapid bronchodilation
- Budesonide: An inhaled corticosteroid that suppresses airway inflammation by inhibiting multiple inflammatory cells and mediators
Together, they provide both immediate bronchodilation and anti-inflammatory effects to improve asthma control.